Antibiotics and Antibiotic Resistance—Mur Ligases as an Antibacterial Target

Abstract

The emergence of Multidrug Resistance (MDR) strains of bacteria has accelerated the search for new antibacterials. The specific bacterial peptidoglycan biosynthetic pathway represents opportunities for the development of novel antibacterial agents. Among the enzymes involved, Mur ligases, described herein, and especially the amide ligases MurC-F are key targets for the discovery of multi-inhibitors, as they share common active sites and structural features.

Keywords

• peptidoglycan biosynthesis
• Mur ligases
• antibacterials
• inhibitors